Vascular Biogenics (VBLT) Tops Q1 EPS by 8c

Vascular Biogenics (NASDAQ: VBLT) reported Q1 EPS of ($0.15), $0.08 better than the analyst estimate of ($0.23).

Cash, cash equivalents and short term deposits as of March 31, 2015 were $34.4 million, compared to $36.8 million at year end 2014.

For earnings history and earnings-related data on Vascular Biogenics (VBLT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c